Charles A Brown1, Prince J Pappoe-Ashong2, Nancy Duah3, Anita Ghansah3, Harry Asmah2, Edwin Afari4, Kwadwo A Koram3. 1. School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Legon, Ghana. cabrown@chs.edu.gh. 2. School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Legon, Ghana. 3. Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Ghana. 4. School of Public Health, College of Health Sciences, University of Ghana, Legon, Ghana.
Abstract
BACKGROUND: Recent studies from different malaria-endemic regions including western Africa have now shown that Plasmodium vivax can infect red blood cells (RBCs) and cause clinical disease in Duffy-negative people, though the Duffy-negative phenotype was thought to confer complete refractoriness against blood invasion with P. vivax. The actual prevalence of P. vivax in local populations in Ghana is unknown and little information is available about the distribution of Duffy genotypes. The aim of this study was to assess the prevalence of P. vivax in both asymptomatic and symptomatic outpatients and the distribution of Duffy genotypes in Ghana. METHODS: DNA was extracted from dried blood spots (DBS) collected from 952 subjects (845 malaria patients and 107 asymptomatic persons) from nine locations in Ghana. Plasmodium species identification was carried out by nested polymerase chain reaction (PCR) amplification of the small-subunit (SSU) rRNA genes. For P. vivax detection, a second PCR of the central region of the Pvcsp gene was carried out. Duffy blood group genotyping was performed by allele-specific PCR to detect the presence of the FYES allele. RESULTS: No cases of P. vivax were detected in any of the samples by both PCR methods used. Majority of infections (542, 94.8%) in the malaria patient samples were due to P. falciparum with only 1 infection (0.0017%) due to Plasmodium malariae, and 2 infections (0.0034%) due to Plasmodium ovale. No case of mixed infection was identified. Of the samples tested for the FYES allele from all the sites, 90.5% (862/952) had the FYES allele. All positive samples were genotyped as FY*B-33/FY*B-33 (Duffy-negative homozygous) and therefore classified as Fy(a-b-). CONCLUSIONS: No cases of P. vivax were detected by both PCRs and majority of the subjects tested carried the FYES allele. The lack of P. vivax infections observed can be attributed to the high frequency of the FYES allele that silences erythroid expression of the Duffy. These results provide insights on the host susceptibility for P. vivax infections that had not been investigated in Ghana before.
BACKGROUND: Recent studies from different malaria-endemic regions including western Africa have now shown that Plasmodium vivax can infect red blood cells (RBCs) and cause clinical disease in Duffy-negative people, though the Duffy-negative phenotype was thought to confer complete refractoriness against blood invasion with P. vivax. The actual prevalence of P. vivax in local populations in Ghana is unknown and little information is available about the distribution of Duffy genotypes. The aim of this study was to assess the prevalence of P. vivax in both asymptomatic and symptomatic outpatients and the distribution of Duffy genotypes in Ghana. METHODS: DNA was extracted from dried blood spots (DBS) collected from 952 subjects (845 malariapatients and 107 asymptomatic persons) from nine locations in Ghana. Plasmodium species identification was carried out by nested polymerase chain reaction (PCR) amplification of the small-subunit (SSU) rRNA genes. For P. vivax detection, a second PCR of the central region of the Pvcsp gene was carried out. Duffy blood group genotyping was performed by allele-specific PCR to detect the presence of the FYES allele. RESULTS: No cases of P. vivax were detected in any of the samples by both PCR methods used. Majority of infections (542, 94.8%) in the malariapatient samples were due to P. falciparum with only 1 infection (0.0017%) due to Plasmodium malariae, and 2 infections (0.0034%) due to Plasmodium ovale. No case of mixed infection was identified. Of the samples tested for the FYES allele from all the sites, 90.5% (862/952) had the FYES allele. All positive samples were genotyped as FY*B-33/FY*B-33 (Duffy-negative homozygous) and therefore classified as Fy(a-b-). CONCLUSIONS: No cases of P. vivax were detected by both PCRs and majority of the subjects tested carried the FYES allele. The lack of P. vivax infections observed can be attributed to the high frequency of the FYES allele that silences erythroid expression of the Duffy. These results provide insights on the host susceptibility for P. vivax infections that had not been investigated in Ghana before.
Authors: Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey Journal: Am J Trop Med Hyg Date: 2007-12 Impact factor: 2.345
Authors: Ivo Mueller; Mary R Galinski; J Kevin Baird; Jane M Carlton; Dhanpat K Kochar; Pedro L Alonso; Hernando A del Portillo Journal: Lancet Infect Dis Date: 2009-09 Impact factor: 25.071
Authors: Cristina Mendes; Fernanda Dias; Joana Figueiredo; Vicenta Gonzalez Mora; Jorge Cano; Bruno de Sousa; Virgílio E do Rosário; Agustin Benito; Pedro Berzosa; Ana Paula Arez Journal: PLoS Negl Trop Dis Date: 2011-06-21
Authors: Márcia A Alexandre; Cynthia O Ferreira; André M Siqueira; Belisa L Magalhães; Maria Paula G Mourão; Marcus V Lacerda; Maria das Gracas C Alecrim Journal: Emerg Infect Dis Date: 2010-10 Impact factor: 6.883
Authors: Tarcisio A A Carvalho; Maíse G Queiroz; Greice L Cardoso; Isabela G Diniz; Aylla N L M Silva; Ana Y N Pinto; João F Guerreiro Journal: Malar J Date: 2012-12-22 Impact factor: 2.979